ETR vs PPCB · P/E 28, rev $12.95B vs P/E 0.0, $3.9M cap
Entergy Corporation (ETR) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
PPCB does not have a complete income-statement cache yet.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the ETR and PPCB stock pages for the full models.
Not investment advice.